3 mental health policy issues Boris Johnson’s Government must address

When he’s not testing the rulebook on parliamentary procedure, preparing the country for that inevitable no-deal Brexit, or out on the yet-to-be-declared campaign trail, Boris Johnson likes to tread the line between audacious policy announcements and drafting bullish content for the papers. Back in July Johnson wrote an Op-Ed, citing his hero Winston Churchill and his...

Europe and the supply of innovative medicines: why it matters

One of the standout features of the ‘no-deal’ Brexit debate has been the focus on the impact on supplies of medicines and medicinal products. This includes everything from chemical compounds and investigational medicinal products (IMPs) for clinical research through to short shelf-life medicines made on the continent. The debate has been a continuous battle between those outlining the possible impact on patients’ lives while struggling to quantify the extent of the impact. Some areas...

Outcomes-based pricing for medicines: a solution to the tug of war?

The Government this week announced that it will trial new outcomes-based pricing for antibiotics. Specifically in the battle against AMR. It is time to look at innovative pricing models. And to ask if they can end the tug of war over price between industry and government. There is a paradox in the relationship between the pharmaceutical industry and the Government in relation to medicine pricing. The typical story is that the Government turns to industry for solutions, be they...

logo
Ian Perrin 5th Mar, 2019 Strategy
Health , NHS
5 min read

Artificial Intelligence: UK ‘pharmatech’ industry growth

Artificial Intelligence (AI) has been a mainstay in the public’s vocabulary for several years now. Tech revolutionaries have painted a futuristic and transformed world, if not a dystopian one; but only recently have we started to understand what this means for the ordinary citizen, such how it is transforming consumer healthcare. The ever-faster power of computer processors, the ability to house and...

logo
Ian Perrin 4th Dec, 2018 Insight
pharma
4 min read

Sin Taxes : everything that you need to know

Sin taxes, as they’ve come to be known, have made increasingly regular appearances in political circles over recent times. They’re championed by tributary policy wonks as an example of a smart policy instrument. Health bodies herald them as a win-win for both public health and the public purse. Parliamentarians see them as a quick victory with the voters. In the UK, their mention came to the fore again earlier this year with the introduction of the now well-known “sugar tax”. The tax...

logo
Ian Perrin 21st Sep, 2018 Insight